{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:16:24Z","timestamp":1780049784341,"version":"3.53.1"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T00:00:00Z","timestamp":1362614400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0056044","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T21:58:48Z","timestamp":1362693528000},"page":"e56044","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["How Methodologic Differences Affect Results of Economic Analyses: A Systematic Review of Interferon Gamma Release Assays for the Diagnosis of LTBI"],"prefix":"10.1371","volume":"8","author":[{"given":"Olivia","family":"Oxlade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anete","family":"Trajman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (2011) Global Tuberculosis Control: WHO Report 2011."},{"key":"ref2","unstructured":"World Health Organization (2010) Policy Framework for Implementing New Tuberculosis Diagnostics."},{"key":"ref3","unstructured":"Drummond MF, O\u2019Brien B, Stoddart GL, Torrance GW (2005) Methods for the Economic Evaluation of Health Care Prgrams, 2nd Edition. Oxford: Oxford Univeristy Press."},{"key":"ref4","unstructured":"The Cochrane Collaboration (2011) Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. Updated March 2011."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"M Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"D Menzies","year":"2007","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/bmj.313.7052.275","article-title":"Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party","volume":"313","author":"MF Drummond","year":"1996","journal-title":"BMJ"},{"key":"ref8","unstructured":"[Anonymous] (2012) European Commission - Eurostat."},{"key":"ref9","unstructured":"[Anonymous] (2012) Bank of England."},{"key":"ref10","unstructured":"[Anonymous] (2012) Bank of Canada."},{"key":"ref11","unstructured":"[Anonymous] (2012) Bureau of Labor Statistics."},{"key":"ref12","unstructured":"[Anonymous] (2012) International Monetary Fund."},{"key":"ref13","first-page":"962","article-title":"Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico","volume":"13","author":"JL Burgos","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archinternmed.2008.524","article-title":"Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers","volume":"169","author":"MA de Perio","year":"2009","journal-title":"Arch Intern Med"},{"key":"ref15","first-page":"471","article-title":"Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection","volume":"14","author":"S Deuffic-Burban","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1378\/chest.06-2728","article-title":"Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany","volume":"131","author":"R Diel","year":"2007","journal-title":"Chest"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1183\/09031936.00145906","article-title":"Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis","volume":"30","author":"R Diel","year":"2007","journal-title":"Eur Respir J"},{"key":"ref18","first-page":"5","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-alpha antagonist therapy","volume":"367\u2013373","author":"A Kowada","year":"2010","journal-title":"Mol Diagn Ther 14"},{"key":"ref19","first-page":"4","article-title":"Cost effectiveness of interferon-gamma release assay versus chest X-ray for tuberculosis screening of BCG-vaccinated elderly populations","volume":"229\u2013236","author":"A Kowada","year":"2010","journal-title":"Mol Diagn Ther 14"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF03256289","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan","volume":"12","author":"A Kowada","year":"2008","journal-title":"Mol Diagn Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201101-0181OC","article-title":"Priorities for screening and treatment of latent tuberculosis infection in the United States","volume":"184","author":"BP Linas","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref22","first-page":"1414","article-title":"Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts","volume":"12","author":"F Marra","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref23","first-page":"16","article-title":"Interferon-gamma release assays and TB screening in high income countries: A cost effectiveness analysis. The International Journal of Tuberculosis and Lung Disease","volume":"11","author":"O Oxlade","year":"2006"},{"key":"ref24","first-page":"S1473","article-title":"Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis","volume":"435\u2013444","author":"M Pareek","year":"2011","journal-title":"Lancet Infect Dis 11"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2466-10-7","article-title":"Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis","volume":"10","author":"A Pooran","year":"2010","journal-title":"BMC Pulm Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.1996.03540160061034","article-title":"Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine","volume":"276","author":"JE Siegel","year":"1996","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/14737167.8.2.165","article-title":"Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold","volume":"8","author":"SD Grosse","year":"2008","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Dowdy DW, Cattamanchi A, Steingart KR, Pai M (2011) Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis. PLOS Med 8: e1001063. PMEDICINE-D-11-00763 [pii]. doi:10.1371\/journal.pmed.1001063.","DOI":"10.1371\/journal.pmed.1001063"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Nienhaus A, Schablon A, Costa JT, Diel R (2011) Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC Health Serv Res 11: 247. 1472-6963-11-247 [pii];doi:10.1186\/1472-6963-11-247.","DOI":"10.1186\/1472-6963-11-247"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0056044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:26:20Z","timestamp":1540337180000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0056044"}},"subtitle":[],"editor":[{"given":"Joel Joseph","family":"Gagnier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,7]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0056044","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,7]]}}}